Predictive Oncology Inc.
POAI
$0.96
-$0.03-3.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.44M | -2.17M | -- | -3.18M | -4.22M |
| Total Depreciation and Amortization | 166.10K | 573.60K | -- | 164.20K | 152.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 387.00K | -14.00K | -- | 119.40K | -52.00K |
| Change in Net Operating Assets | 1.13M | -538.50K | -- | -320.40K | 702.40K |
| Cash from Operations | -756.30K | -2.15M | -- | -3.22M | -3.42M |
| Capital Expenditure | -- | 0.00 | -- | -6.50K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 625.00K | 0.00 | -- | -- | -- |
| Cash from Investing | 625.00K | 0.00 | -- | -6.50K | -3.00K |
| Total Debt Issued | -- | 0.00 | -- | 275.10K | -- |
| Total Debt Repaid | -- | -195.80K | -- | -38.00K | -112.40K |
| Issuance of Common Stock | 2.58M | 0.00 | -- | 3.70M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -79.70K | 0.00 | -- | -573.80K | -- |
| Cash from Financing | 2.50M | -195.80K | -- | 3.36M | -112.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.37M | -2.34M | -- | 134.50K | -3.53M |